4 transcripts
NTRA
Earnings call transcript
NASDAQ
2024 Q2
8 Aug 24
and another strong quarter of ASP growth. Volumes were up over 23% compared to Q2 of last year.
We had a great quarter winning new accounts in women's
NTRA
Earnings call transcript
NASDAQ
2024 Q1
9 May 24
2021, when the volumes were less than half the size they are now.
We had record volumes across oncology, organ health and women's health. In oncology
NTRA
Earnings call transcript
NASDAQ
2023 Q4
28 Feb 24
of 73.5%, and we also saw strong growth metrics in women's health and organ health.
Gross margins in Q4 came in at 51.4% compared to our Q1 margin
NTRA
Earnings call transcript
NASDAQ
2023 Q2
3 Aug 23
is proving to be a pivotal trial, and I'll share some of those findings here shortly.
In women's health, we published the fourth paper from the SMART
- Prev
- 1
- Next